Osteoporosis is a disease that gives women a risk of 30-40% of having an osteoporotic fracture in their lifetime. The lifetime risk for men is approximately 13%.*

Osteometer MediTech's focus is on offering affordable, high quality office based scanners and densitometers for diagnosis of osteoporosis. Since the first densitometer left the factory more than ten years ago, several thousand densitometers have followed, and today Osteometer MediTech is the market leader in office based densitometry in several countries around the globe.

Quality and reliability are key elements for Osteometer MediTech. From development to manufacturing, Osteometer MediTech complies with the following standards:

IEC 60601-1-2 Medical Electrical Equipment (General requirements for safety)
The Medical Device Directive (93/42/EEC)
ISO 13485: 2003 (E) 
Furthermore, Osteometer's products are in compliance with the Food, Drug and Cosmetic Act (FDA), CFR Part 21, Title 820 (GMP).

Being one of the main market players within diagnosis of osteoporosis, Osteometer MediTech is committed to developing scientifically and clinically validated devices. This has resulted in accurate, precise, reliable and cost-effective scanners, making the diagnostic test accessible to as many patients as possible.